Early changes in serum type ii collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placeboIdentification of urinary peptide biomarkers associated with rheumatoid arthritis.Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial.Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.Biomarkers of rheumatoid arthritis: recent progress.Biomarkers in psoriatic arthritis: a systematic literature review.Novel multiplex technology for diagnostic characterization of rheumatoid arthritis.Synovial tissue research: a state-of-the-art review.Current Trends in Cartilage Science: An Impression from the ICRS World Conference 2012.A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis.Proteomes, Their Compositions and Their Sources.Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
P2860
Q27687777-FC78748D-6C8A-4D7E-9542-7BA9F9272D67Q28475485-925CE7A6-503D-443F-BE71-A4D7BF93CC05Q34075303-C858B605-762E-440B-99FF-C9573DB883E1Q34281891-4A8E2417-B2F8-416A-BC78-8C75B9F4AE4EQ35557805-C7F2AC6E-6F9F-427D-B84B-392983001E0CQ37462448-0120B263-DFFA-4D5F-B0E2-5F659D505930Q38089869-6D581F80-79C9-45DC-9641-895D19484DC2Q38715137-652F5C0E-5DBB-44A8-ACA3-AE5C0091F7D7Q39186261-FA3C3F28-D163-4E38-998C-D6F57179DD2EQ39431367-2B2D6269-7975-487C-822E-6CA559731506Q40840800-50CAB0DD-1E75-49A6-AB96-D7C59E65B659Q50960278-0734E467-2601-42AE-9DEB-2AC9AFCF0049Q51263649-36DAAC9E-D6D7-4C33-8CA4-94FC9E51C2DAQ54339705-79FFB70F-9BC1-40BE-A835-9D9CB7308E75
P2860
Early changes in serum type ii collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy
description
scientific article published on 01 September 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2007
@uk
name
Early changes in serum type ii ...... atients after biologic therapy
@en
Early changes in serum type ii ...... atients after biologic therapy
@nl
type
label
Early changes in serum type ii ...... atients after biologic therapy
@en
Early changes in serum type ii ...... atients after biologic therapy
@nl
prefLabel
Early changes in serum type ii ...... atients after biologic therapy
@en
Early changes in serum type ii ...... atients after biologic therapy
@nl
P2093
P921
P356
P1476
Early changes in serum type II ...... atients after biologic therapy
@en
P2093
A Robin Poole
Barry Bresnihan
Clare Matthews
Lindsay King
Oliver FitzGerald
Ronan H Mullan
P304
P356
10.1002/ART.22843
P577
2007-09-01T00:00:00Z